Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Cash from Investing Activities (2016 - 2025)

Plus Therapeutics has reported Cash from Investing Activities over the past 16 years, most recently at -$1.1 million for Q4 2025.

  • Quarterly Cash from Investing Activities fell 1782.81% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$854000.0 through Dec 2025, up 79.23% year-over-year, with the annual reading at -$854000.0 for FY2025, 79.23% up from the prior year.
  • Cash from Investing Activities was -$1.1 million for Q4 2025 at Plus Therapeutics, down from $1.3 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $3.6 million in Q1 2025 and troughed at -$4.6 million in Q2 2025.
  • The 5-year median for Cash from Investing Activities is -$42000.0 (2023), against an average of -$351058.8.
  • Year-over-year, Cash from Investing Activities plummeted 34463.64% in 2024 and then soared 14511.11% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$84000.0 in 2021, then soared by 86.9% to -$11000.0 in 2022, then plummeted by 281.82% to -$42000.0 in 2023, then surged by 252.38% to $64000.0 in 2024, then plummeted by 1782.81% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Cash from Investing Activities are -$1.1 million (Q4 2025), $1.3 million (Q3 2025), and -$4.6 million (Q2 2025).